Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial

2018 ◽  
Vol 67 (1) ◽  
pp. 184-192 ◽  
Author(s):  
Bo Yang ◽  
Lin Shi ◽  
Ai-min Wang ◽  
Mei-qi Shi ◽  
Zi-hao Li ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Randomized Controlled Trial ◽  
Fatty Acid ◽  
Angiotensin Ii ◽  
Inner Mongolia ◽  
Controlled Trial ◽  
Double Blind ◽  
Hypertensive Patients ◽  
Randomized Controlled ◽  
Plasma Angiotensin

Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: a randomized controlled trial

2019 ◽  
Vol 10 (3) ◽  
pp. 1661-1670 ◽  
Author(s):  
Bo Yang ◽  
Mei-qi Shi ◽  
Zi-hao Li ◽  
Lin Shi ◽  
Ai-min Wang ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Randomized Controlled Trial ◽  
Fatty Acid ◽  
Inner Mongolia ◽  
Controlled Trial ◽  
Reduce Blood Pressure ◽  
Hypertensive Patients ◽  
Randomized Controlled ◽  
Drug Treatments

Daily supplementation with n-3 fatty acid (FA) has been believed to be an adjunct or alternative to drug treatments to reduce blood pressure (BP) and triglyceride (TG) levels in western patients with high risk of cardiovascular disease.

Sign in / Sign up

Export Citation Format

Share Document